16th July 2019
Baxter brings new competencies to enhance the network
EIT Health France is thrilled to welcome Baxter. Providing a broad portfolio of essential healthcare products, Baxter is a global healthcare company.
Its portfolio includes acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anaesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products.
Baxter’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care. Baxter operates a global manufacturing network and its products are sold in more than 100 countries around the world, and they are used in a variety of care settings, including hospitals, kidney dialysis centres, nursing homes, rehabilitation centres, doctors’ offices and by patients at home under physician supervision. Baxter maintains a global R&D footprint, including locations in the United States, Asia and in Europe, where we operate facilities in countries such as Belgium, Germany, Italy among others.
Baxter is thrilled to become a member of the EIT Health network. They are looking forward to continuing to build open innovation partnerships which drive forward their mission of saving and sustaining lives, adding to recently announced collaborations like Mayo Clinic, Tel Aviv University/Tel Aviv Sourasky Medical Center, and MATTER Healthcare Incubator. Baxter brings to its partnerships a mix of broad experience across a range of products, therapies, and technologies, brand/product strength, global reach, and commercial, market, regulatory, and clinical expertise.
Baxter is particularly interested in opportunities/partnerships in the critical care/ICU, operating room, and renal care (home/clinic/hospital) settings. They are open to diverse partnerships and ones that cross industries lines.
Please visit Baxter for more information.
For further enquiries contact:
Albane Pariset, firstname.lastname@example.org
EIT Health helps Tubulis secure €10.7M in funding
Investor Network aids firm doing antibody work
EIT Health-backed start-ups garner big investments
A million each for iLoF and Restorative Neurotechnologies
EIT Health aids 11 start-ups disrupted by COVID-19
Start-up Rescue Instrument gives €5.5M in co-investment